Evaluating allogeneic transplant for TP53 mutated acute myeloid leukemia

A new editorial was published in Oncotarget’s Volume 15 on October 1, 2024, entitled, “Transplant or no transplant for TP53 mutated AML.”

Updated Food Compass 2.0 improves food health ratings using new diet data

Food Compass 2.0 refines the original nutrient profiling system by incorporating updated health data and ingredient assessments. This system offers more accurate scoring of foods

October 13, 2024

Opinion | ‘I Guess You Negotiate With a Mugger’: What We Heard This Week

“I guess you negotiate with a mugger when they show up. It’s your money or your life.” — Craig Garthwaite, PhD, an economist at Northwestern

December 18, 2023

Is It a Sports Injury, or Something More Serious?

WASHINGTON — Though seemingly rare, osteosarcoma can masquerade as a sports-related injury, a physician said at the American Academy of Pediatrics annual meeting. In fact,

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.